Immunovia AB 2023 AR2
The report highlights Immunovia's significant corporate transformation in 2023, including the decision to withdraw the IMMray™ PanCan-d test from the market to focus resources on its next-generation pancreatic cancer detection test. The company underwent extensive restructuring, reducing its workforce by 80% and transitioning to a commercially available ELISA platform to lower production costs. Immunovia successfully completed a discovery study evaluating nearly 3,000 proteins and identifying 15 promising biomarkers for early-stage pancreatic cancer detection. Additionally, the report outlines the company's ESG approach, focusing on public welfare, sustainable products, and maintaining a sustainable workplace.
Company: Immunovia AB
Sector: Professional & technical services
Country: Sweden
Year: 2023
Type: AR2
Pages: 76
Back to company
Immunovia AB
Annual Report
The report highlights Immunovia's significant corporate transformation in 2023, including the decision to withdraw the IMMray™ PanCan-d test from the market to focus resources on its next-generation pancreatic cancer detection test. The company underwent extensive restructuring, reducing its workforce by 80% and transitioning to a commercially available ELISA platform to lower production costs. Immunovia successfully completed a discovery study evaluating nearly 3,000 proteins and identifying 15 promising biomarkers for early-stage pancreatic cancer detection. Additionally, the report outlines the company's ESG approach, focusing on public welfare, sustainable products, and maintaining a sustainable workplace.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Published
Apr 29, 2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees